🟢 92/100

This product looks safe

  • Zinc: 50mg is 1.2× the Tolerable Upper Intake Level (40mg)
  • 40% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Zinc: 50mg is 1.2× the Tolerable Upper Intake Level (40mg)

Label Data

10 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
40% Evidence Coverage

Supplement Facts — Evidence Check

90 mg (22.5% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 90mg
50 mg (333% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.2× (UL: 40 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 50mg UL 40mg
Potent Strength & Testosterone Boosting Matrix
Virility, LH & FSH Stimulation
Estrogen & Prolactin Regulation

Other Ingredients

Cellulose Gelatin Silica Magnesium Stearate FD&C Blue #1 FD&C Red #40

Label Claims — Verification

Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult Male (18-50 Years)

Product Information

🧪 Formulation Notes

Explosive testosterone boosting Powerful libido boosting Androgen potentiation Energy enhancement Cortisol modulation Mood elevation

Supercharged pct

Turning men into demigods

Ultra premium post cycle therapy specialist Scientifically backed with clinical doses Estrogen Eliminator

Additional Information

Innovation. Value. Results.

3rd party tested Made in U.S.A. GMP Good Manufacturing Practice

Product Details

DSLD Entry Date 2020-11-21
Product Type Other Combinations
Form Capsule
Brand Olympus Labs
DSLD ID 240293
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →